IPXL
Impax Laboratories, Inc.
IPXL
IPXL
Delisted
IPXL was delisted on the 4th of May, 2018.
200 hedge funds and large institutions have $1.24B invested in Impax Laboratories, Inc. in 2017 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 71 increasing their positions, 51 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less capital invested
Capital invested by funds: $1.38B → $1.24B (-$135M)
Holders
200
Holding in Top 10
1
Calls
$1.41M
Puts
$315K
Top Buyers
| 1 | +$68.9M | |
| 2 | +$32.3M | |
| 3 | +$28.6M | |
| 4 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$18.5M |
| 5 |
MC
Maverick Capital
Dallas,
Texas
|
+$13.9M |
Top Sellers
| 1 | -$20.4M | |
| 2 | -$13.3M | |
| 3 | -$12.4M | |
| 4 |
BM
Bridger Management
New York
|
-$12.2M |
| 5 |
ECP
Empyrean Capital Partners
Los Angeles,
California
|
-$10.5M |